SCHEMBL4696095

SCHEMBL4696095

CCCC(C)(Oc1ccc(CNC(=O)Cc2cc(-c3ccc(C(C)(C)C)cc3)nn2C)cc1C)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 0.61
PPARG P37231 19/20 0.61
PPARD Q03181 11/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805399 0.89 PPARA (0.75) PPARAPPARGPPARD
SCHEMBL4692465 0.86 PPARG (0.61) PPARAPPARGPPARD
SCHEMBL4696094 0.85 PPARA (0.62) PPARAPPARGPPARD
SCHEMBL4695140 0.80 PPARG (0.68) PPARAPPARGPPARD
SCHEMBL4692287 0.80 PPARA (0.71) PPARAPPARGPPARD
SCHEMBL4689583 0.79 PPARG (0.67) PPARAPPARGPPARD
SCHEMBL4750583 0.79 PPARG (0.67) PPARAPPARGPPARD
SCHEMBL4692539 0.78 PPARG (0.66) PPARAPPARGPPARD
SCHEMBL4694582 0.77 PPARG (0.67) PPARAPPARGPPARD
SCHEMBL4691567 0.77 PPARG (0.81) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685113-B1 SUBSTITUTED PYRAZOLES AS PPAR AGONISTS SMITHKLINE BEECHAM CORP (US) 2008-07-30 EP disclosed
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists SMITHKLINE BEECHAM CORPORATION 2008-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021030-A1 Substituted Pyrazoles As Ppar Agonists PPARD, PPARA, PPARG PPARA 2/4885PPARG 3/4885PPARD 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.